| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |